PureTech Health (PRTC) EBIT (2024 - 2025)

PureTech Health (PRTC) reported EBIT of -$43.9 million for Q2 2025, up 20.3% on a QoQ basis from -$55.0 million in Q4 2024.

PureTech Health (PRTC) has 2 years of EBIT data on file, last reported at -$43.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -2.97 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -15.76 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 1.14 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 642.90 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - -3.82 Mn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 268.64 Mn
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -43.86 Mn
Dec 31, 2024 -55.03 Mn